Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
165 JPY | +3.12% | +19.57% | 0.00% |
02:43am | Healios Enters Alliance, Bond Purchase Deal with Alfresa | MT |
Apr. 10 | Healios Partners with AND Medical Group; Set to Receive Upfront Payment of 60 Million Yen | MT |
Sales 2024 * | 300M 1.92M | Sales 2025 * | 1.47B 9.4M | Capitalization | 14.42B 92.35M |
---|---|---|---|---|---|
Net income 2024 * | -3.29B -21.06M | Net income 2025 * | -2.31B -14.77M | EV / Sales 2024 * | 45.3 x |
Net cash position 2024 * | 822M 5.26M | Net Debt 2025 * | 608M 3.89M | EV / Sales 2025 * | 10.2 x |
P/E ratio 2024 * |
-4.01
x | P/E ratio 2025 * |
-5.62
x | Employees | 64 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.9% |
1 day | +3.13% | ||
1 week | +19.57% | ||
Current month | +4.43% | ||
1 month | +5.77% | ||
3 months | +19.57% | ||
6 months | -9.84% |
Managers | Title | Age | Since |
---|---|---|---|
Hardy Kagimoto
CEO | Chief Executive Officer | 47 | 11-02-23 |
Richard Kincaid
DFI | Director of Finance/CFO | 47 | 18-02-28 |
Masanori Sawada
CTO | Chief Tech/Sci/R&D Officer | 42 | 12-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 12-12-31 | |
Director/Board Member | 72 | 18-02-28 | |
Hardy Kagimoto
CEO | Chief Executive Officer | 47 | 11-02-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 165 | +3.12% | 5 543 600 |
24-06-05 | 160 | -3.61% | 1,093,000 |
24-06-04 | 166 | +4.40% | 1,245,500 |
24-06-03 | 159 | +0.63% | 2,703,600 |
24-05-31 | 158 | +14.49% | 2,634,900 |
Delayed Quote Japan Exchange, June 06, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 92.33M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.40% | 22.67B | |
-9.68% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- 4593 Stock